The Business Times
business-time-50
SUBSCRIBERS

Pfizer sues Johnson & Johnson over anti-competitive tactics

It claims J&J acted to squash its cheaper version of powerful rheumatoid arthritis drug

google-preferred-sourceAdd BT as a preferred source
Published Thu, Sep 21, 2017 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Washington

A LEGAL brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost of the most advanced and expensive medicines.

Pfizer filed a lawsuit on Wednesday against fellow pharmaceutical giant Johnson & Johnson for using "anti-competitive" tactics to squash its cheaper version of a powerful rheumatoid arthritis drug.

Pfizer

Share with us your feedback on BT's products and services

Feedback

TRENDING NOW

DBS filed the bankruptcy application after serving statutory demands to the directors of Autobahn Rent A Car in December 2025.

Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS

The price tag for the Nassim Road GCB works out to nearly S$4,550 per square foot.

Nassim Road bungalow changing hands for S$64.9m 

The acquisition of Citigroup's retail banking businesses in Indonesia, Malaysia, Thailand and Vietnam has helped double UOB’s customer base across the four markets.

UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates

Loyang Valley sits on a 840,648 sq ft plot of land, which now houses 362 apartments.

Loyang Valley sold for S$880 million to SingHaiyi-led consortium

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More